Filing Flows › Aptargroup (ATR) › Q2 2025
Aptargroup (ATR) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 1, 2025
Aptargroup (ATR) reported revenue of $966M for the second quarter 2025 (Q2 2025), +6% from a year earlier and +9% from the quarter before. Operating margin was 14.9%, net earnings $112M (11.6% of revenue).
Aptargroup, Q2 2025: revenue $966M (+6% year over year), operating margin 14.9%, net earnings $112M, operating cash flow $126M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $966M | +9% | +6% |
| Operating profit | $144M | +27% | +15% |
| Net earnings | $112M | +42% | +24% |
| Operating cash flow | $126M | +52% | -12% |
| Free cash flow | $65.8M | — | -13% |
What changed
Revenue was $966.0M in Q2 2025, up 6% year over year and up 9% from the previous quarter. Aptar Pharma was the largest line at 46% of revenue. Aptar Pharma added $28.1M year over year (up 7%), 50% of the total change.
Operating profit was $144.4M, a 14.9% margin (up 1.1 points year over year). Of the extra revenue versus a year earlier, 33% reached operating profit, above the 14% margin then. Total costs grew 5% against revenue growth of 6%. Net earnings were $111.7M, up 24% year over year. The effective tax rate was 20.0%.
Operating cash flow was $126.0M (down 12% year over year), 113% of net earnings. Non-cash charges added back $69.9M of depreciation and amortization and $8.0M of share-based compensation. Working capital and other items used $63.7M. After capital Expenditures, net ($60.1M), free cash flow as the company reports it was $65.8M.
Questions
What was Aptargroup's revenue in the second quarter 2025?
Aptargroup (ATR) reported revenue of $966M for the second quarter 2025 (Q2 2025), +6% from a year earlier and +9% from the quarter before.
Was Aptargroup profitable in the second quarter 2025?
Operating profit was $144M (14.9% of revenue) and net earnings $112M.
Source: Aptargroup 10-Q on SEC EDGAR.